Accenture (NYSE: ACN) has been named a Leader in an IDC Health Insights IDC MarketScape vendor assessment covering business process outsourcing (BPO) across the life sciences research and development (R&D) industry. This is the third consecutive time Accenture Life Sciences has achieved this prestigious ranking.
The report, “IDC MarketScape: Worldwide Life Science R&D BPO 2018 Vendor Assessment" (IDC #US42144618, June 2018), examines the current life sciences R&D BPO landscape, including industry and market trends, comparing major vendors against the criteria most important for life sciences companies to consider when selecting a service provider.
Alan Louie, Ph.D, research director for IDC Health Insights Life Sciences practice, notes in his report, “Accenture has extensive experience working with life science companies across all three sections of the industry: pharmaceutical, biotech, and medical devices. Building on an aggressive growth and acquisition strategy, Accenture has diversified significantly beyond its traditional big pharma focus and has grown its presence among emerging and mid-tier life science companies in recent years. Relative to other vendors discussed in this study, and based on feedback from multiple customer references, Accenture received high marks for transparent integration into client teams, working as a vested partner, and helping the client improve operational efficiencies across a widening portfolio of efforts.”
Kevin Julian, senior managing director in Accenture’s Life Sciences practice, said, “This leadership positioning in the IDC MarketScape emphasizes our focus on providing best-in-class solutions to top global and emerging pharmaceutical, biotech and medical device companies. We’re pleased to be recognized for the third consecutive time by IDC as a high-quality BPO service provider, demonstrating the breadth of our understanding of this dynamic industry across company-specific, strategic and tactical levels.”
In naming Accenture Life Sciences as a Leader, the IDC MarketScape looked at:
For the purposes of this analysis, IDC Health Insights divided potential key measures for success into two primary categories: capabilities and strategies. The assessment includes client references.
Click here to learn more about Accenture’s Life Sciences practice and the Accenture Accelerated R&D Services.
About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.
Accenture is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions – underpinned by the world’s largest delivery network – Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders. With 449,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives. Visit us at www.accenture.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180712005081/en/